The NIH is currently spending $200 million on a decade-long trial called Look AHEAD to test the hypothesis that if obese diabetics lose weight they’ll be healthier for the effort. This is “the largest, most expensive trial ever funded by NIH for obesity outcome research,” says the Baylor University psychologist John Foreyt, who is one of the trial’s principal investigators. But once again, the trial tests only the conventional wisdom. The goal of Look AHEAD is to induce five thousand obese diabetics to lose weight by the same lifestyle modification used in the Diabetes Prevention Program: cutting calories and fat calories, and exercising. If these obese diabetics do lose weight, and if they do end up healthier for it, we still won’t know whether it was the calories, the fat calories, the exercise, some combination of all three, or maybe just the carbohydrates or the sugar that made the difference. And we won’t know whether, if they restricted carbohydrates alone and ate protein and fat to their hearts’ content, they would have been healthier still.

Because these trials are planned as a test of only one hypothesis—and a poorly defined hypothesis at that—the research ensures that we won’t have the kind of reliable answers that we so desperately need. If the Diabetes Prevention Program had included a test of the carbohydrate hypothesis, the investigators could have compared the effect of a low-fat, low-calorie diet and exercise to the effect of carbohydrate restriction alone, and that would have told us whether it’s the carbohydrates or the calories and the sedentary behavior that cause these chronic diseases. If Look AHEAD were to include a test of the carbohydrate hypothesis, we might at least know the answer in another decade. It doesn’t, and we won’t.